Black Rock Inc. Emergent Bio Solutions Inc. Call Options Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding EBS
# of Institutions
137Shares Held
35.6MCall Options Held
78.7KPut Options Held
75.1K-
Charles Schwab Investment Management Inc San Francisco, CA4.15MShares$32.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$27.1 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.91MShares$15.1 Million0.19% of portfolio
-
Morgan Stanley New York, NY1.29MShares$10.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.12MShares$8.89 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $395M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...